Detection of bemitil and its metabolite in urine by means of LC-MS/MS in view of doping control analysis.
Kwiatkowska D, Kowalczyk K, Grucza K, Szutowski M, Bulska E, Wicka M · 2018 · Drug testing and analysis; 2018 Nov
Study findings
In six healthy volunteers, urine analysis detected Bemitil and its glucuronide conjugate. The conjugate was more abundant and detectable for longer. This was a detection study, not a performance trial.
- Population and setting
- Healthy adult volunteers
- Evidence type
- Analytical / composition study
- Preparation
- See the original report; formulation details require verification.
- Source language
- eng
- Title source
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
Study limitations
- Full text and detailed methods have not been independently assessed.
- Pharmacokinetic or analytical measurements do not establish clinical efficacy or a safe dosing regimen.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Indexed citation and English abstract checked.
Recorded source-check date: 2026-10-07. This date does not imply a completed systematic review.
Open original source or index record ↗
DOI: 10.1002/dta.2524
Citation and original source
Original source: Kwiatkowska D, Kowalczyk K, Grucza K, Szutowski M, Bulska E, Wicka M. Detection of bemitil and its metabolite in urine by means of LC-MS/MS in view of doping control analysis. Drug testing and analysis; 2018 Nov 2018.
Molekul research summary: https://molekul.io/research/bemitil-extra-30346653. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry